Raised S.B. No. 1473
Session Year 2025
 


AN ACT REQUIRING MEDICAID COVERAGE FOR FDA-APPROVED GENE THERAPIES TO TREAT SICKLE CELL DISEASE.

To require Medicaid coverage for gene therapies approved by the federal Food and Drug Administration to treat sickle cell disease.

Introduced by:
Human Services Committee

 New today  2-4 days old  5 days & older

Co-sponsors for Amendment LCO:

Bill History

 Date Action Taken
 6/23/2025Signed by the Governor
 6/9/2025Transmitted by Secretary of the State to Governor
 6/9/2025Transmitted to the Secretary of State
 6/3/2025(LCO)Public Act 25-63
 5/31/2025In Concurrence
 5/31/2025House Passed
 5/2/2025House Calendar Number 526
 5/2/2025Favorable Report, Tabled for the Calendar, House
 5/1/2025Senate Passed
 4/1/2025(LCO)File Number 384
 4/1/2025Senate Calendar Number 235
 4/1/2025Favorable Report, Tabled for the Calendar, Senate
 4/1/2025(LCO)Reported Out of Legislative Commissioners' Office
 3/25/2025(LCO)Referred to Office of Legislative Research and Office of Fiscal Analysis 03/31/25 5:00 PM
 3/17/2025(LCO)Filed with Legislative Commissioners' Office
 3/14/2025(HS)Joint Favorable
 3/7/2025Public Hearing 03/11
 3/6/2025Referred to Joint Committee on Human Services

Co-sponsors of SB-1473

Rep. Sarah Keitt, 134th Dist.
Sen. Saud Anwar, 3rd Dist.
Sen. Patricia Billie Miller, 27th Dist.
Sen. Joan V. Hartley, 15th Dist.
Sen. Matthew L. Lesser, 9th Dist.
Rep. Kenneth Gucker, 138th Dist.
Rep. Nick Gauthier, 38th Dist.
Sen. Paul Cicarella, 34th Dist.
Rep. Patricia A. Dillon, 92nd Dist.
Sen. John A. Kissel, 7th Dist.

NOTE: Please direct all inquiries regarding the status of bills to the Office of the House Clerk and/or Senate Clerks' Office.